PharmaShots Weekly Snapshots (April 26 - 30, 2021)
Published: Apr 30, 2021 | Tags: BMS, US, FDA, Opdivo, sBLA, Priority Review, nivolumab, Muscle Invasive Urothelial Carcinoma
Janssen Reports MAA Submission to EMA for Cilta-cel to Treat Relapsed/ Refractory Multiple Myeloma
Published: Apr 30, 2021 | Tags: Janssen, MAA, Submission, EMA, Cilta-cel, Relapsed/ Refractory, Multiple Myeloma
Published: Apr 30, 2021 | Tags: Repertoire, Yale University, Antigen, T- Cell Receptor, Multiple Sclerosis
Published: Apr 30, 2021 | Tags: Celltrion, Results, Regdanvimab, CT-P59, Pre-Clinical, Study, South African Variant, B.1.351
Published: Apr 30, 2021 | Tags: Innovent, First Patient, Dosing, P-II, Trial, IBI302, Neovascular Age-Related Macular Degeneration
Published: Apr 30, 2021 | Tags: Alphamab, Pfizer, Initiate, P-II, Trial, KN046, Inlyta, axitinib, Non-Small Cell Lung Cancer
Published: Apr 29, 2021 | Tags: Angion, Vifor Pharma, Completion, Patient Enrollment, P-II, AKI-002-15 Study, ANG-3777, Cardiac-Surgery, Acute Kidney Injury
Alcon to Acquire Exclusive US Commercialization Rights to Novartis' Simbrinza
Published: Apr 29, 2021 | Tags: Alcon, Exclusive, US, Commercialization Rights, Novartis, Simbrinza
Published: Apr 29, 2021 | Tags: BeiGene, Results, Brukinsa (zanubrutinib), P-III, APSEN Trial, R/R Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
BioMarin Collaborates with Allen Institute to Develop Gene Therapies for Rare Brain Diseases
Published: Apr 29, 2021 | Tags: BioMarin, Allen Institute, Develop, Gene Therapies, Rare Brain Diseases
Organicell Reports the Expansion of its Trial for Zofin to Treat COVID-19 Patients in India
Published: Apr 29, 2021 | Tags: Organicell, Expansion, Trial, Zofin, Treat, COVID-19, India
Pfizer Acquires Amplyx to Expand its Infectious Disease Portfolio
Published: Apr 29, 2021 | Tags: Pfizer, Amplyx, Expand, Infectious Disease
Voluntis Collaborates with Eisai to Develop Digital Therapeutics for Oncology Patients
Published: Apr 28, 2021 | Tags: Voluntis, Eisai, Develop, Digital Therapeutics, Oncology
LogicBio Signs an Option Agreement with Canbridge to Develop Gene Editing Therapies
Published: Apr 28, 2021 | Tags: LogicBio, Option Agreement, Canbridge, Develop, Gene Editing Therapies
InveniAI Collaborates with Shionogi on AI-Based Drug Discovery
Published: Apr 28, 2021 | Tags: InveniAI, Shionogi, AI-Based, Drug Discovery
Published: Apr 28, 2021 | Tags: Y-mAbs, MAA, Submission, EMA, Omburtamab, CNS/Leptomeningeal Metastasis, Neuroblastoma
Abbott Launches AI-Powered Coronary Imaging Platform in Europe
Published: Apr 28, 2021 | Tags: Abbott, Launches, AI-Powered, Coronary Imaging Platform, Europe
Published: Apr 28, 2021 | Tags: US, FDA, Priority Review, Takeda, Mobocertinib, TAK-788, EGFR Exon20 Insertion, Metastatic, Non-Small Cell Lung Cancer
Glenmark's Ryaltris Nasal Spray Receives EC's Approval as 1L Treatment for Allergic Rhinitis
Published: Apr 27, 2021 | Tags: Glenmark, Ryaltris Nasal Spray, EC, Approval, Treatment, Allergic Rhinitis
Daiichi Sankyo Expands its Collaboration with Esperion to Additional Territories
Published: Apr 27, 2021 | Tags: Daiichi Sankyo, Expands, Esperion, Additional, Territories
Pieris Out-licenses PRS-342 to Boston Pharmaceuticals for ~$363M
Published: Apr 27, 2021 | Tags: Pieris, Out-licenses, PRS-342, Boston Pharmaceuticals, ~$363M
I-Mab Reports Results of Olamkicept (TJ301) in P-II Study for Ulcerative Colitis
Published: Apr 27, 2021 | Tags: I-Mab, Results, Olamkicept, TJ301, P-II Study, Ulcerative Colitis
Medtronic Collaborates with Surgical Theater to Provide Augmented Reality Platform to Neurosurgery
Published: Apr 27, 2021 | Tags: Medtronic, Surgical Theater, Augmented Reality Platform, Neurosurgery
Published: Apr 27, 2021 | Tags: Biocon Biologics, Viatris, European Commission, Approval, Abevmy
Published: Apr 26, 2021 | Tags: AstraZeneca, Tagrisso, osimertinib, EU, CHMP, Positive Opinion, Early-Stage, EGFR-Mutated Lung Cancer
Published: Apr 26, 2021 | Tags: AstraZeneca, MSD, Selumetinib, EU, CHMP, Positive Opinion, First Therapy, Neurofibromatosis Type 1 Plexiform Neurofibromas
Published: Apr 26, 2021 | Tags: Sanofi, AstraZeneca, Results, Nirsevimab, P-III, MELODY Study, Respiratory Syncytial Virus Disease
Published: Apr 26, 2021 | Tags: Dermavant, Results, Tapinarof, Two, P-III, Trials, Psoriasis
Published: Apr 26, 2021 | Tags: GSK, Jemperli, dostarlimab, EC, Approval, Recurrent, Advanced, dMMR/MSI-H, Endometrial Cancer
Published: Apr 26, 2021 | Tags: BMS, Results, Deucravacitinib, Two, P- III Trials, Moderate, Severe, Plaque Psoriasis
Related Post: PharmaShots Weekly Snapshots (Apr 19 - 23, 2021)
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com